Evidence map›Paper›PMID 29581554›Full record

Trial reportJournal of human hypertension2018

Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker.

Tuuli Teeäär, Martin Serg, Kaido Paapstel, Jaak Kals, Mart Kals, Mihkel Zilmer, Jaan Eha, Priit Kampus

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of human hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tuuli TeeäärDepartment of Cardiology, Institute of Clinical Medicine, University of Tartu, 8 Puusepa Street, Tartu, 51014, Estonia. tuuli.teeaar@kliinikum.ee.
Martin SergDepartment of Cardiology, Institute of Clinical Medicine, University of Tartu, 8 Puusepa Street, Tartu, 51014, Estonia.
Kaido PaapstelDepartment of Cardiology, Institute of Clinical Medicine, University of Tartu, 8 Puusepa Street, Tartu, 51014, Estonia.
Jaak KalsDepartment of Biochemistry, Centre of Excellence for Genomics and Translational Medicine, Institute of Biomedicine and Translational Medicine, University of Tartu, 19 Ravila Street, Tartu, 50411, Estonia.
Mart KalsEstonian Genome Center, University of Tartu, 23b Riia Street, Tartu, 51010, Estonia.
Mihkel ZilmerDepartment of Biochemistry, Centre of Excellence for Genomics and Translational Medicine, Institute of Biomedicine and Translational Medicine, University of Tartu, 19 Ravila Street, Tartu, 50411, Estonia.
Jaan EhaDepartment of Cardiology, Institute of Clinical Medicine, University of Tartu, 8 Puusepa Street, Tartu, 51014, Estonia.
Priit KampusDepartment of Cardiology, Institute of Clinical Medicine, University of Tartu, 8 Puusepa Street, Tartu, 51014, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased resting heart rate (HR) contributes to higher cardiovascular mortality and morbidity in the healthy as well as in people with cardiovascular diseases, possibly due to elevated blood pressure (BP) among other mechanisms. Data on the relationship between HR and central (aortic) BP remains controversial, however, and concerning β-blockers, it has been proposed that pharmacological HR lowering is associated with augmentation of central BP. We aimed to study the role of pharmacologically unaffected HR on central BP indices in sick sinus syndrome patients with a permanent cardiac pacemaker in the HR range from 40 to 90 bpm. We included 27 subjects (mean age 65.8 ± 9.5 years, 12 men) with a dual-chamber pacemaker implanted due to sick sinus syndrome. We determined central hemodynamic indices noninvasively during an atrial pacing mode at low (40 bpm), middle (60 bpm), and high (90 bpm) HR levels with an oscillometric cuff-based device (Sphygmocor XCEL). There was no difference in central systolic BP at the middle versus the high HR level (mean 121.2 ± 13.0 and 121.2 ± 12.1 mmHg, respectively, P = 0.9), but at the low HR level, it was significantly lower than at the middle HR level (mean 117.2 ± 13.1 and 121.2 ± 13.0 mmHg, P < 0.01). Our acute study provides evidence to suggest that at a HR of <60 bpm, sick sinus syndrome patients may have a lower central BP than at a higher HR, despite the proposed augmenting effects of low HR on central BP.

Indexed as

Blood PressureHeart RateAgedFemaleHumansMaleMiddle AgedPacemaker, ArtificialSick Sinus Syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.